Scilex Holding Co Files 8-K: Regulation FD Disclosure
Ticker: SCLXW · Form: 8-K · Filed: Jun 21, 2024 · CIK: 1820190
| Field | Detail |
|---|---|
| Company | Scilex Holding Co (SCLXW) |
| Form Type | 8-K |
| Filed Date | Jun 21, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001, $11.50, $10 million, $10.4 million |
| Sentiment | neutral |
Sentiment: neutral
Topics: disclosure, regulation-fd
Related Tickers: SCLX
TL;DR
Scilex filed an 8-K for a Reg FD disclosure. No new material info disclosed.
AI Summary
On June 21, 2024, Scilex Holding Company filed an 8-K report detailing a Regulation FD Disclosure. The filing does not contain specific financial figures or new material events beyond the disclosure itself.
Why It Matters
This filing indicates Scilex Holding Co is making a public disclosure under Regulation FD, ensuring all investors receive the same material information simultaneously.
Risk Assessment
Risk Level: low — The filing is a standard disclosure and does not report any new material events, financial changes, or significant business developments.
Key Players & Entities
- Scilex Holding Company (company) — Registrant
- Delaware (jurisdiction) — State of incorporation
- Palo Alto, California (location) — Business and mailing address
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to provide a Regulation FD Disclosure.
What is the date of the earliest event reported in this filing?
The date of the earliest event reported is June 21, 2024.
What is the exact name of the registrant as specified in its charter?
The exact name of the registrant is Scilex Holding Company.
In which state was Scilex Holding Company incorporated?
Scilex Holding Company was incorporated in Delaware.
What is the business address of Scilex Holding Company?
The business address of Scilex Holding Company is 960 San Antonio Road, Palo Alto, California, 94303.
Filing Stats: 624 words · 2 min read · ~2 pages · Grade level 14 · Accepted 2024-06-21 06:05:34
Key Financial Figures
- $0.0001 — ich registered Common stock, par value $0.0001 per share SCLX The Nasdaq Stock Mar
- $11.50 — mon stock, each at an exercise price of $11.50 per share SCLXW The Nasdaq Stock Ma
- $10 million — ds in the aggregate principal amount of $10 million (the " Deposit "). As of June 21, 202
- $10.4 million — n the aggregate amount of approximately $10.4 million to Oramed Pharmaceuticals Inc. (" Orame
Filing Documents
- d788214d8k.htm (8-K) — 25KB
- 0001193125-24-165059.txt ( ) — 183KB
- sclxw-20240621.xsd (EX-101.SCH) — 4KB
- sclxw-20240621_def.xml (EX-101.DEF) — 14KB
- sclxw-20240621_lab.xml (EX-101.LAB) — 23KB
- sclxw-20240621_pre.xml (EX-101.PRE) — 15KB
- d788214d8k_htm.xml (XML) — 6KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. SCILEX HOLDING COMPANY By: /s/ Jaisim Shah Name: Jaisim Shah Title: Chief Executive Officer and President Date: June 21, 2024 3